Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Irene Manrique
The Mechanism of Action of the Anti-Cd38 Monoclonal Antibody Isatuximab in Multiple Myeloma
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Mechanism of Action of a New Anti-Cd38 Antibody: Enhancing Myeloma Immunotherapy
Clinical Cancer Research
Cancer Research
Oncology
213Bi Radioimmunotherapy With an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
The Therapeutic Human CD38 Antibody Daratumumab Improves the Anti-Myeloma Effect of Newly Emerging Multi-Drug Therapies
Blood Cancer Journal
Oncology
Hematology
Phase I Trial of Isatuximab Monotherapy in the Treatment of Refractory Multiple Myeloma
Blood Cancer Journal
Oncology
Hematology
CD26 Is a Potential Therapeutic Target by Humanized Monoclonal Antibody for the Treatment of Multiple Myeloma
Blood Cancer Journal
Oncology
Hematology
Current Use of Monoclonal Antibodies in the Treatment of Multiple Myeloma
British Journal of Haematology
Hematology
CD38-driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma
Cancer Research
Cancer Research
Oncology
CD38-Targeted Immunochemotherapy in Refractory Multiple Myeloma: A New Horizon
Clinical Cancer Research
Cancer Research
Oncology
Phase I Study of the Anti-FcRH5 Antibody-Drug Conjugate DFRF4539A in Relapsed or Refractory Multiple Myeloma
Blood Cancer Journal
Oncology
Hematology